Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma-Reference-Cited by-同舟云学术

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma

Published:2011-10-04 Issue:5 Volume:75 Page:585-591
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Kroiss Matthias,Quinkler Marcus,Lutz Werner K.,Allolio Bruno,Fassnacht Martin

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2011.04214.x/fullpdf

Reference77 articles.

1. Adrenocortical carcinoma: a clinician’s update;Fassnacht;Nature Reviews Endocrinology,2011

2. Regression of adrenal cancer and suppression of adrenal function in men by o,p-DDD;Bergenstal;Transactions of theAssociation of American Physicians,1959

3. Adjuvant mitotane treatment for adrenocortical carcinoma;Terzolo;New England Journal of Medicine,2007

4. Mitotane for adrenocortical carcinoma treatment;Hahner;Current Opinion in Investigational Drugs,2005

5. Mitotane has a strong and a durable inducing effect on CYP3A4 activity;van Erp;European Journal of Endocrinology,2011

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of mitotane in the management of adrenocortical cancer;The Oncologist;2024-07-22

2. Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics;Frontiers in Endocrinology;2024-05-08

3. Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial;The Lancet Oncology;2024-05

4. International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects;European Journal of Endocrinology;2024-03-29

5. Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma;European Journal of Endocrinology;2024-01-19